Eloxx Pharmaceuticals Inc. (ELOX)
ELOX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.70
-8.57% on the day
Market cap
$51.3M
Micro cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$6.0M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ELOX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001035354 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$6.0M |
| Operating income | -$6.4M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $4.8M |
| Total assets | $5.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-09-11 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy FORM DEFA14A | DEFA14A | 2023-04-28 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
| KLRS | Kalaris Therapeutics Inc. | $2.23 | -1.33% | $53.1M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| LONA | LeonaBio Inc. | $6.43 | +4.30% | $60.6M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier